Hepatitis B  >>  Pegasys (pegylated interferon α -2a)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pegasys (pegylated interferon α -2a) / Roche
NCT02908191: A Study in Healthy Volunteers and Patients With Chronic Hepatitis B

Completed
1a/1b
86
RoW
ABI-H0731, Placebo for ABI-H0731, Sugar pill manufactured to mimic the ABI-H0731 tablet, Entecavir, Tenofovir disoproxil fumarate, Pegasys, peginterferon alfa-2a, Nucleos(t)ide
Assembly Biosciences
Chronic Hepatitis B
03/18
06/18
NCT02401737: Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV Patients

Completed
1b
58
US, RoW
NVR 3-778, Placebo for NVR 3-778, Pegasys, peginterferon alfa-2a
Novira Therapeutics, Inc.
Chronic Hepatitis B
05/16
05/16
NCT00962871: A Study of Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both

Completed
1
30
US, RoW
peginterferon alfa-2a [Pegasys], tenofovir
Hoffmann-La Roche
Hepatitis B, Chronic
02/12
02/12
NCT00962975: A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous Studies

Completed
1
29
US, RoW
peginterferon alfa-2a [Pegasys]
Hoffmann-La Roche
Hepatitis B, Chronic
05/13
05/13
NCT02112799: Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients

Completed
1
55
RoW
NVR 3-778, Placebo for NVR 3-778, Pegasys, peginterferon alfa-2a
Novira Therapeutics, Inc.
Chronic Hepatitis B
05/16
05/16

Download Options